glp-1 masld The Interplay Between GLP-1-Based Therapies, the Gut Microbiome, and MASLD/MASH in Type 2 Diabetes Mellitus: A Narrative Review Incretin-based therapies in MASLD/MASH: from

KDOQI clinical practice guideline for diabetes and CKD: 2012 update

doi:10.2174/1573399811309020007 39

These changes are typical and reflect the body reverting to its natural physiological state without active medication support

GLP-1 medications are often used when diet, exercise, and other medicines have not provided enough benefit

While GLP-1 medications are meant for long-term use, this is not always feasible for every patient

Although quality of life scores did not significantly change, the trial highlights clinically significant changes in functional mobility and shows direct vascular benefits from GLP-1 RAs [26]